Guggenheim Capital’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-37,327
Closed -$2.4M 2498
2018
Q3
$2.4M Buy
37,327
+15,963
+75% +$973K 0.02% 1136
2018
Q2
$1.04M Sell
21,364
-66,188
-76% -$3.43M 0.01% 1591
2018
Q1
$4.11M Sell
87,552
-16,428
-16% -$790K 0.01% 1131
2017
Q4
$5.18M Buy
103,980
+40,821
+65% +$2.03M 0.01% 1018
2017
Q3
$3.66M Sell
63,159
-4,634
-7% -$276K 0.01% 1249
2017
Q2
$4.55M Sell
67,793
-37,072
-35% -$2.34M 0.01% 1076
2017
Q1
$6.87M Sell
104,865
-19,475
-16% -$1.2M 0.02% 845
2016
Q4
$7.06M Buy
124,340
+73,200
+143% +$4.23M 0.02% 819
2016
Q3
$3.03M Sell
51,140
-2,775
-5% -$167K 0.01% 1329
2016
Q2
$3.52M Sell
53,915
-1,000
-2% -$68K 0.01% 1191
2016
Q1
$3.8M Buy
54,915
+4,502
+9% +$300K 0.01% 1140
2015
Q4
$3.7M Buy
50,413
+31,976
+173% +$2.27M 0.01% 1188
2015
Q3
$1.31M Sell
18,437
-14,701
-44% -$1.19M ﹤0.01% 1938
2015
Q2
$2.88M Buy
33,138
+2,347
+8% +$177K 0.01% 1488
2015
Q1
$2.26M Buy
30,791
+6,794
+28% +$482K 0.01% 1667
2014
Q4
$1.73M Sell
23,997
-33,398
-58% -$2.31M ﹤0.01% 1850
2014
Q3
$3.97M Sell
57,395
-2,337
-4% -$164K 0.01% 1335
2014
Q2
$3.71M Buy
59,732
+5,804
+11% +$340K 0.01% 1375
2014
Q1
$2.94M Buy
53,928
+15,608
+41% +$834K 0.01% 1468
2013
Q4
$2.02M Sell
38,320
-14,248
-27% -$715K 0.01% 1781
2013
Q3
$2.45M Sell
52,568
-3,152
-6% -$151K 0.01% 1479
2013
Q2
$2.72M Buy
+55,720
New +$2.67M 0.01% 1339

Other funds holding LPNT

Guggenheim Capital's LPNT Position: Q4 2018 in Review

Guggenheim Capital sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 37,327 shares — an estimated $2.4M sold.

Guggenheim Capital first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $7.06M in Q4 2016. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • Guggenheim Capital reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Guggenheim Capital sold 37,327 LifePoint Health, Inc. shares in Q4 2018, an estimated $2.4M.
  • Guggenheim Capital first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
  • Guggenheim Capital's LifePoint Health, Inc. position peaked at $7.06M in Q4 2016.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Guggenheim Capital's 13F filing for Q4 2018, filed 14 Feb 2019.